LET’S GET TECHNICAL. Scientists from the biotech company Life Biosciences are investigating the safety and potential side ...
Morning Overview on MSN
The first cellular age-reversal therapy has been cleared for human trials
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...
A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...
Recent data published in NEJM demonstrates that CRISPR gene-editing therapy achieves complete clinical efficacy endpoints in ...
All living organisms are known to inherit genes, DNA sequences that contain instructions for producing specific proteins and ...
Morning Overview on MSN
A Harvard scientist says his team is preparing the first human trials aimed at reversing aging
A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...
Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...
For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...
Combined company to operate as Remix Therapeutics and advance Remix’s pipeline of novel small molecule therapies designed to reprogram RNA ...
Butyrate, produced when gut bacteria ferment dietary fiber, was shown to influence immune-cell identity, trafficking, and ...
Researchers found that loss of GATA6 reprograms colorectal cancer cells into flexible, fetal-like states that can spread to ...
A new international clinical intervention study published in Clinical Nutrition reveals the molecular and transcriptomic mechanisms through which a dietary intervention may beneficially influence gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results